Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000675916 | SCV000344143 | uncertain significance | not provided | 2018-01-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001450070 | SCV001030530 | likely benign | Wolman disease | 2024-10-12 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000675916 | SCV000801643 | uncertain significance | not provided | 2017-05-16 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001083223 | SCV001456945 | uncertain significance | Lysosomal acid lipase deficiency | 2020-04-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004543131 | SCV004759372 | likely benign | LIPA-related disorder | 2021-10-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |